Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Reinfection and Resistance Associated Substitutions Following a Minimal Monitoring Approach for Hepatitis C Virus Treatment in MINMON Trial

Clinical Infectious Diseases(2024)10.1093/cid/ciae627Source: DataRank Database

Reinfection and Resistance Associated Substitutions Following a Minimal Monitoring Approach for Hepatitis C Virus Treatment in MINMON Trial is a research paper published in Clinical Infectious Diseases (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access0 citations

Download PDF

Cite:

Linked data & code

nct

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT03512210

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.00)OA: greenTopics (49)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Sunil S. Solomon ORCID,Laura Smeaton ORCID,Anchalee Avihingsanon ORCID,Sandra Wagner-Cardoso,Jiani Li ORCID

Live enrichment

PubMed:39702964 PMC:PMC12272843 OpenAlex:https://openalex.org/W4405652976

National Institutes of Health

Grant: UM1 AI068634

National Institutes of Health

Grant: UM1 AI068636

National Institutes of Health

Grant: UM1 AI106701

National Institute of Allergy and Infectious Diseases

FWCI

0.00

Citation Percentile

0.3%

greenLicense: https://academic.oup.com/pages/standard-publication-reuse-rights

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12272843/pdf/ciae627.pdf

publisherhttps://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciae627/61242161/ciae627.pdf

publisherhttps://academic.oup.com/cid/article-pdf/80/6/1293/61242161/ciae627.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12272843/

Fields of Study

Hepatitis C virus researchHIV/AIDS drug development and treatmentHIV Research and TreatmentAdultFemaleHumansMaleMiddle AgedAntiviral AgentsDrug Resistance, ViralGenotypeHepacivirusHepatitis CHepatitis C, ChronicPhylogenyReinfectionRNA, ViralSustained Virologic ResponseTreatment FailureViral Nonstructural ProteinsFeasibility StudiesRNA-Dependent RNA Polymerase

MeSH Terms

Sustained Virologic ResponseReinfectionAdultAntiviral AgentsFeasibility StudiesFemaleGenotypeHepatitis CHumansMaleMiddle AgedPhylogenyRNA-Dependent RNA PolymeraseRNA, ViralHepacivirusTreatment FailureViral Nonstructural ProteinsHepatitis C, ChronicDrug Resistance, Viral

Keywords

MedicineInternal medicineVirologyhepatitis CreinfectionNext-generation SequencingResistance-associated SubstitutionsMinimal Monitoring

Sustainable Development Goals

SDG 0: Good health and well-being

Reinfection and Resistance Associated Substitutions Following a Minimal Monitoring Approach for Hepatitis C Virus Treatment in MINMON Trial

FAIR Checklist

Authors (13)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)